- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- F-4 Registration of securities (foreign)
- 3.2 Exhibit 3.2
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 23.3 Exhibit 23.3
- 23.7 Exhibit 23.7
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- EX-FILING FEES Ex-filing Fees
- 21 Feb 23 424B3 Prospectus supplement
- 8 Feb 23 424B3 Prospectus supplement
- 8 Feb 23 EFFECT Notice of effectiveness
- 3 Feb 23 F-4/A Registration of securities (foreign) (amended)
- 25 Jan 23 F-4/A Registration of securities (foreign) (amended)
- 13 Jan 23 F-4/A Registration of securities (foreign) (amended)
-
28 Dec 22 F-4 Registration of securities (foreign)
Exhibit 99.4
December 28, 2022
YishengBio Co., Ltd
Building No. 2, 38 Yongda Road
Daxing Biomedical Industry Park
Daxing District, Beijing
People’s Republic of China
Ladies and Gentlemen:
Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the references to my name in the Registration Statement on Form F-4 (the “Registration Statement”) of YishengBio Co., Ltd (the “Company”) and any amendments thereto, which indicate that I have accepted the nomination to become a director of the Company. I further agree that immediately upon the United States Securities and Exchange Commission’s declaration of effectiveness of the Registration Statement, I will serve as a member of the board of directors of the Company.
Sincerely yours,
/s/ Bo Tan | |
Name: Bo Tan |
[Signature page to Consent of Director Appointee to F-4]